ARCHIVES

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

Bunn To Succeed Norton As ASCO President, Tempero Is President-Elect

April 26, 2002

In Brief: The Anatomy Of An Administrative Nightmare: How NIH Spent $518 Million In One Day

October 23, 1992

CCOP Application Now Total 180 Plus

November 26, 1982

NCI Taps Harlow To Head Office of Science Policy

July 26, 1996

Donald Berry To Step Down From Departmental Posts At MD Anderson

November 26, 2010

The Cancer Letter Provides Full Text Of Publications To University Of Kentucky.

October 19, 2001